AMGN(AMGN)
AMGN
Next report
Nov 3 2026in 26 days
EPS estimate
$5.78
Revenue estimate
$10.05B
EPS beats
11 of last 12
EPS surprise
Each report against the estimate that stood when it landed.
Oct 31 2023Aug 4 2026
| Reported | EPS est | EPS actual | Surprise | Revenue est | Revenue actual | Surprise |
|---|---|---|---|---|---|---|
| Aug 4 2026 | $5.62 | $6.29 | +11.9% | $9.43B | $10.05B | +6.7% |
| Apr 30 2026 | $4.77 | $5.15 | +8.0% | $8.58B | $8.62B | +0.5% |
| Feb 3 2026 | $4.73 | $5.29 | +11.8% | $9.47B | $9.87B | +4.1% |
| Nov 4 2025 | $5.02 | $5.64 | +12.4% | $8.97B | $9.56B | +6.6% |
| Aug 5 2025 | $5.28 | $6.02 | +14.0% | $8.94B | $9.17B | +2.6% |
| May 1 2025 | $4.27 | $4.90 | +14.8% | $8.06B | $8.15B | +1.1% |
| Feb 4 2025 | $5.04 | $5.31 | +5.4% | $8.88B | $9.09B | +2.3% |
| Oct 30 2024 | $5.11 | $5.58 | +9.2% | $8.50B | $8.50B | +0.1% |
| Aug 6 2024 | $4.98 | $4.97 | -0.2% | $8.35B | $8.39B | +0.4% |
| May 2 2024 | $3.88 | $3.96 | +2.1% | $7.45B | $7.45B | -0.1% |
| Feb 6 2024 | $4.59 | $4.71 | +2.6% | $8.13B | $8.20B | +0.9% |
| Oct 31 2023 | $4.65 | $4.96 | +6.7% | $6.62B | $6.90B | +4.3% |
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+3.67%
EPS+6.07%
FY2028
Rev+3.26%
EPS+5.56%
FY2029
Rev+3.82%
EPS+6.76%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $38.96B | $40.39B | $41.70B | $43.30B | $45.12B |
| Low | $38.55B | $39.18B | $38.15B | $41.86B | $43.62B |
| High | $39.55B | $41.98B | $46.88B | $45.72B | $47.65B |
| EBITDA Avg | $21.67B | $21.90B | $22.20B | $23.08B | $24.00B |
| Low | $21.37B | $20.78B | $19.34B | $22.34B | $23.21B |
| High | $22.01B | $22.67B | $24.41B | $24.32B | $25.33B |
| EBIT Avg | $17.24B | $18.04B | $18.80B | $20.02B | $21.21B |
| Low | $16.94B | $16.92B | $15.93B | $19.28B | $20.42B |
| High | $17.58B | $18.81B | $21.00B | $21.27B | $22.54B |
| Net Income Avg | $12.51B | $13.22B | $13.88B | $14.95B | $15.99B |
| Low | $12.25B | $12.24B | $11.37B | $14.30B | $15.30B |
| High | $12.81B | $13.89B | $15.81B | $16.04B | $17.15B |
| EPS Avg | $23.08 | $24.47 | $25.84 | $27.58 | $29.49 |
| Low | $22.60 | $22.58 | $20.98 | $26.39 | $28.22 |
| High | $23.64 | $25.63 | $29.17 | $29.59 | $31.64 |
| Analysts (Rev / EPS) | 24 / 20 | 24 / 20 | 28 / 11 | 22 / 4 | 26 / 4 |
Quarterly
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 | Q3 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $10.25B | $9.41B | $10.27B | $10.18B | $10.58B | $9.38B | $10.22B | $10.31B |
| Low | $9.96B | $9.10B | $9.94B | $9.86B | $10.24B | $9.08B | $9.89B | $9.98B |
| High | $10.45B | $9.64B | $10.52B | $10.44B | $10.85B | $9.62B | $10.47B | $10.56B |
| EBITDA Avg | $5.32B | $5.16B | $5.56B | $5.45B | $5.56B | $5.18B | $5.64B | $5.51B |
| Low | $4.99B | $5.01B | $5.39B | $5.29B | $5.39B | $5.03B | $5.46B | $5.35B |
| High | $5.53B | $5.27B | $5.68B | $5.58B | $5.69B | $5.30B | $5.77B | $5.64B |
| EBIT Avg | $4.28B | $4.15B | $4.58B | $4.51B | $4.64B | $4.29B | $4.77B | $4.67B |
| Low | $3.95B | $4.00B | $4.42B | $4.34B | $4.47B | $4.14B | $4.60B | $4.50B |
| High | $4.49B | $4.26B | $4.71B | $4.63B | $4.76B | $4.41B | $4.90B | $4.80B |
| Net Income Avg | $3.16B | $3.05B | $3.43B | $3.36B | $3.48B | $3.17B | $3.59B | $3.51B |
| Low | $2.88B | $2.92B | $3.28B | $3.22B | $3.33B | $3.04B | $3.44B | $3.36B |
| High | $3.34B | $3.15B | $3.54B | $3.47B | $3.59B | $3.28B | $3.71B | $3.62B |
| EPS Avg | $5.81 | $5.61 | $6.30 | $6.18 | $6.39 | $5.83 | $6.60 | $6.44 |
| Low | $5.29 | $5.37 | $6.04 | $5.92 | $6.12 | $5.59 | $6.33 | $6.18 |
| High | $6.15 | $5.79 | $6.50 | $6.38 | $6.60 | $6.02 | $6.82 | $6.65 |
| Analysts (Rev / EPS) | 15 / 17 | 7 / 7 | 7 / 15 | 7 / 9 | 7 / 7 | 13 / 9 | 13 / 8 | 13 / 14 |
AI Earnings SummaryQ2 2026
Checking for summary...
Last reported Earnings history refreshes daily; a new report appears within about 2 daysAbout this data
Explore More
Healthcare Stocks
More Healthcare stocks
AMGN vs ABBV
Compare AMGN and ABBV side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Strategy Focus List
Continuous multi-factor scoring & catalyst forensics
Market Movers
Today's biggest gainers and losers
